QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-fourth of one Redeemable Warrant |
||||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
☒ | Smaller reporting company | |||||
Emerging growth company |
Page |
||||||
Item 1. |
FINANCIAL STATEMENTS (UNAUDITED) | |||||
Condensed Balance Sheets | 1 | |||||
Condensed Statements of Operations | 2 | |||||
Condensed Statements of Changes in Stockholders’ Equity (Deficit) | 3 | |||||
Condensed Statements of Cash Flows | 4 | |||||
Notes to Condensed Financial Statements | 5 | |||||
Item 2. |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | 22 | ||||
Item 3. |
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK | 25 | ||||
Item 4. |
CONTROLS AND PROCEDURES | 25 | ||||
Item 1. |
LEGAL PROCEEDINGS | 26 | ||||
Item 1A. |
RISK FACTORS | 26 | ||||
Item 2. |
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS | 27 | ||||
Item 3. |
DEFAULTS UPON SENIOR SECURITIES | 27 | ||||
Item 4. |
MINE SAFETY DISCLOSURES | 27 | ||||
Item 5. |
OTHER INFORMATION | 27 | ||||
Item 6. |
EXHIBITS | 27 | ||||
28 |
September 30, 2021 |
December 31, 2020 |
||||||||
(Unaudited) | |||||||||
ASSETS |
|||||||||
Current assets: |
|||||||||
Cash |
$ | $ | |||||||
Prepaid expenses |
— | ||||||||
Total current assets |
|||||||||
Deferred offering costs |
— | ||||||||
Investments held in Trust Account |
— | ||||||||
Total Assets |
$ |
$ |
|||||||
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY |
|||||||||
Current liabilities: |
|||||||||
Accrued expenses |
$ | $ | — | ||||||
Franchise tax payable |
— | ||||||||
Sponsor note |
— | ||||||||
Total current liabilities |
|||||||||
Warrant liabilities |
— | ||||||||
Deferred underwriting fee payable |
— | ||||||||
Total Liabilities |
|||||||||
Commitments (see Note 7) |
|||||||||
Class A common stock, subject to possible redemption; September 30, 2021 and December 31, 2020, respectively |
— | ||||||||
Stockholders’ (Deficit) Equity: |
|||||||||
Preferred stock, $ 2021 and December 31, 2020, respectively |
|||||||||
Class A common stock, $ shares subject to possible redemption) at September 30, 2021 and December 31, 2020 |
— | ||||||||
Class B authorized; (1) and (2) shares issued and outstanding at September 30, 2021 and December 31, 2020, respectively |
|||||||||
Additional paid-in capital |
— | ||||||||
Accumulated deficit |
( |
) | — | ||||||
Total Stockholders’ (Deficit) Equity |
( |
) | |||||||
Total Liabilities and Stockholders’ (Deficit) Equity |
$ |
$ |
|||||||
(1) | Excludes 4 ). |
(2) | Includes an aggregate of up to |
Three Months Ended September 30, 2021 |
Nine Months Ended September 30, 2021 |
For the Period from July 6, 2020 (inception) Through September 30, 2020 |
||||||||||
Operating and formation costs |
$ | $ | $ | |||||||||
Franchise tax expense |
— | |||||||||||
|
|
|
|
|
|
|||||||
Loss from operations |
( |
) | ( |
) | — | |||||||
Transaction costs allocated to warrant liabilities |
— | ( |
) | — | ||||||||
Net gain on investments held in Trust Account |
— | |||||||||||
Excess of private placement warrant fair value over purchase price |
— | ( |
) | — | ||||||||
Change in fair value of warrant liabilities |
— | |||||||||||
|
|
|
|
|
|
|||||||
Net income |
$ | $ | $ | — | ||||||||
|
|
|
|
|
|
|||||||
Basic and diluted weighted average shares outstanding, Class A common stock |
— | |||||||||||
|
|
|
|
|
|
|||||||
Basic and diluted net income per share, Class A common stock |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Basic and diluted weighted average shares outstanding Class B common stock |
||||||||||||
|
|
|
|
|
|
|||||||
Basic and diluted net income per share, Class B common stock |
$ | $ | $ |
Common Stock |
||||||||||||||||||||||||||||
Class A |
Class B |
Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ Equity (Deficit) |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance, December 31, 2020 (1) |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Forfeiture of Class B common stock |
( |
) | ( |
) | — | — | ||||||||||||||||||||||
Accretion of Class A common stock to redemption amount (Restated - see Note 2) |
— | — | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Balance, March 31, 2021 (Restated - see Note 2) |
— | ( |
) | ( |
) | |||||||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance, June 30, 2021 (Restated - see Note 2) |
— | — | — | ( |
) | ( |
) | |||||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
Balance, September 30, 2021 |
— | $ | — | $ | $ | — | $ | ( |
) | $ | ( |
) | ||||||||||||||||
(1) | Includes an aggregate of up to held by the sponsor that were subject to forfeiture to the extent that the underwriter’s over-allotment was not exercised in full, |
Common Stock |
||||||||||||||||||||||||||||
Class A |
Class B (1) |
Additional Paid-in Capital |
Accumulated Earnings |
Total Stockholders’ Equity |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance, July 6, 2020 (inception) |
$ | |||||||||||||||||||||||||||
Sale of Class B common stock to Sponsor |
— | — | — | |||||||||||||||||||||||||
Net income |
— | — | — | — | — | — | ||||||||||||||||||||||
Balance, September 30, 2020 |
$ |
$ |
$ |
$ |
$ |
|||||||||||||||||||||||
(1) | Includes an aggregate of up to shares held by the sponsor that were subject to forfeiture to the extent that the underwriter’s over-allotment was not exercised in full, |
Nine Months Ended September 30, 2021 |
For the Period from July 6, 2020 (inception) Through September 30, 2020 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income |
$ | $ | — | |||||
Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
Transaction costs allocated to warrant liabilities |
— | |||||||
Net gain on investments held in Trust Account |
( |
) | — | |||||
Excess of private placement warrant fair value over purchase price |
— | |||||||
Change in fair value of warrant liabilities |
( |
) | — | |||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
( |
) | — | |||||
Accrued Expenses |
— | |||||||
Franchise tax payable |
— | |||||||
|
|
|
|
|||||
Net cash used in operating activities |
( |
) | ||||||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Cash deposited into Trust Account |
( |
) | — | |||||
|
|
|
|
|||||
Net cash used in investing activities |
( |
) | — | |||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Proceeds from initial public offering, net of underwriter’s discount paid |
||||||||
Proceeds from sale of Class B common stock to Sponsor |
||||||||
Proceeds from Sponsor note |
||||||||
Repayment of Sponsor note |
( |
) | — | |||||
Proceeds from sale of private placement warrants |
— | |||||||
Payment of offering costs |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net cash provided by financing activities |
||||||||
|
|
|
|
|||||
Increase in cash |
||||||||
Cash at beginning of period |
— | |||||||
|
|
|
|
|||||
Cash at end of period |
$ |
$ |
||||||
|
|
|
|
|||||
Supplemental disclosure of noncash investing and financing activities: |
||||||||
Deferred underwriting fee payable |
$ | $ | — | |||||
|
|
|
|
|||||
Initial classification of warrant liabilities |
$ | $ | — | |||||
|
|
|
|
|||||
Accretion of Class A common stock subject to redemption to redemption value |
$ | $ | — | |||||
|
|
|
|
|||||
Reclassification of deferred offering costs to equity upon completion of the initial public offering |
$ | $ | — | |||||
|
|
|
|
June 30, 2021 |
||||||||||||
As Previously Reported |
Adjustments |
As Restated |
||||||||||
Condensed Balance Sheet (unaudited) |
||||||||||||
Class A common stock subject to possible redemption; |
$ | $ | $ | |||||||||
Class A common stock; |
$ | $ | ( |
) | $ | — | ||||||
Retained earnings (accumulated deficit) |
$ | $ | ( |
) | $ | ( |
) | |||||
Total stockholders’ equity (deficit) |
$ | $ | ( |
) | $ | ) | ||||||
Condensed Statement of Operations for the Three Months Ended June 30, 2021 (unaudited) |
||||||||||||
Basic and diluted weighted average shares outstanding, Class A common stock |
||||||||||||
Basic and diluted net income per share, Class A common stock |
$ |
$ |
$ |
|||||||||
Basic and diluted weighted average shares outstanding, Class B common stock (1) |
( |
) |
||||||||||
Basic and diluted net income per share, Class B common stock |
$ |
$ |
( |
) |
$ |
|||||||
Condensed Statement of Operations for the Six Months Ended June 30, 2021 (unaudited) |
||||||||||||
Basic and diluted weighted average shares outstanding, Class A common stock |
( |
) |
||||||||||
Basic and diluted net income per share, Class A common stock |
$ |
$ |
$ |
|||||||||
Basic and diluted weighted average shares outstanding, Class B common stock (1) |
( |
) |
||||||||||
Basic and diluted net income per share, Class B common stock |
$ |
$ |
( |
) |
$ |
|||||||
Condensed Statement of Changes in Stockholders’ Equity (Deficit) for the Three Months Ended June 30, 2021 (unaudited) |
||||||||||||
Class A common stock subject to possible redemption |
$ |
( |
) |
$ |
$ |
|||||||
Condensed Statement of Cash Flows for the Six Months Ended June 30, 2021 (unaudited) - Supplemental disclosure of non-cash investing and financing activities |
||||||||||||
Class A common stock subject to possible redemption |
$ |
$ |
( |
) |
$ |
|||||||
Accretion of Class A common stock to redemption amount |
(1) |
Prior to the change in presentation for the Class A common stock subject to possible redemption, the Company applied to two class method of earnings per share, allocating net income between redeemable Class A common stock and non-redeemable Class A and Class B common stock. As such, a portion of the Class A common stock was included in the weighted average shares outstanding of Class B common stock in the As Previously Reported balances. |
March 31, 2021 |
||||||||||||
As Previously Reported |
Adjustments |
As Restated |
||||||||||
Condensed Balance Sheet (unaudited) |
||||||||||||
Accrued expenses |
||||||||||||
Class A common stock subject to possible redemption; |
$ | $ | $ | |||||||||
Class A common stock; |
$ | $ | ( |
) | $ | — | ||||||
Additional paid-in capital |
$ | $ | ( |
) | $ | — | ||||||
Accumulated deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Total stockholders’ equity (deficit) |
$ | $ | ( |
) | $ | ( |
) | |||||
Condensed Statement of Operations for the Three Months Ended March 31, 2021 (unaudited) |
||||||||||||
Basic and diluted weighted average shares outstanding, Class A common stock |
( |
) |
||||||||||
Basic and diluted net loss per share, Class A common stock |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Basic and diluted weighted average shares outstanding, Class B common stock (1) |
( |
) |
||||||||||
Basic and diluted net loss per share, Class B common stock |
$ |
( |
) |
$ |
$ |
( |
) | |||||
Condensed Statement of Changes in Stockholders’ Equity (Deficit) for the Three Months Ended March 31, 2021 (unaudited) |
||||||||||||
Sale of |
( |
) |
||||||||||
Class A common stock subject to possible redemption |
( |
) |
||||||||||
Accretion of Class A common stock to redemption amount |
( |
) |
( |
) | ||||||||
Condensed Statement of Cash Flows for the Three Months Ended March 31, 2021 (unaudited) - Supplemental disclosure of non-cash investing and financing activities |
||||||||||||
Class A common stock subject to possible redemption |
( |
) |
||||||||||
Accretion of Class A common stock to redemption amount |
(1) |
Prior to the change in presentation for the Class A common stock subject to possible redemption, the Company applied to two class method of earnings per share, allocating net income between redeemable Class A common stock and non-redeemable Class A and Class B common stock. As such, a portion of the Class A common stock was included in the weighted average shares outstanding of Class B common stock in the As Previously Reported balances. |
March 4, 2021 |
||||||||||||
As Previously Reported |
Adjustments |
As Re stated |
||||||||||
Balance Sheet (audited) |
||||||||||||
Class A common stock subject to possible redemption; |
$ |
$ |
$ |
|||||||||
Class A common stock; |
$ |
$ |
( |
) |
$ |
— |
||||||
Additional paid-in capital |
$ |
$ |
( |
) |
$ |
— |
||||||
Accumulated deficit |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
Total stockholders’ equity (deficit) |
$ |
$ |
( |
) |
$ |
( |
) |
Gross proceeds |
$ |
|||
Less: |
||||
Proceeds allocated to Public Warrants |
( |
) | ||
Issuance costs allocated to Class A common stock |
( |
) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
||||
|
|
|||
Class A common stock subject to possible redemption |
$ |
|||
|
|
Three Months Ended September 30, 2021 |
Nine Months Ended September 30, 2021 |
For the Period from July 6, 2020 (inception) Through September 30, 2020 |
||||||||||||||||||||||
Class A |
Class B |
Class A |
Class B |
Class A |
Class B |
|||||||||||||||||||
Basic and diluted net income per share: |
||||||||||||||||||||||||
Numerator: |
||||||||||||||||||||||||
Net income |
$ | $ | $ | |
$ | |
$ | $ | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Denominator: |
||||||||||||||||||||||||
Basic and diluted weighted average shares outstanding |
|
|
— | |||||||||||||||||||||
Basic and diluted net income per share |
$ | $ | $ | |
$ | |
$ | $ |
• | in whole and not in part; |
• | at a price of $ |
• | upon not less than “30-day redemption period”) to each warrant holder; and |
• | if, and only if, the reported last sale price of the Class A common stock equals or exceeds $ |
Description |
Amount at Fair Value |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
September 30, 2021 |
||||||||||||||||
Assets |
||||||||||||||||
Investments held in Trust Account: |
||||||||||||||||
Money Market investments |
$ | $ | $ | — | $ | — | ||||||||||
Liabilities |
||||||||||||||||
Warrant liability – Public Warrants |
$ | $ | $ | — | $ | — | ||||||||||
Warrant liability – Private Placement Warrants |
$ | $ | — | $ | — | $ | ||||||||||
December 31, 2020 |
||||||||||||||||
Assets |
||||||||||||||||
Investments held in Trust Account: |
||||||||||||||||
Money Market investments |
$ | $ | $ | $ | ||||||||||||
Liabilities |
||||||||||||||||
Warrant liability – Public Warrants |
$ | $ | $ | $ | ||||||||||||
Warrant liability – Private Placement Warrants |
$ | $ | $ | $ |
As of March 4, 2021 |
||||
Stock Price on Valuation Date |
$ | |||
Strike price (Exercise Price Share) |
$ | |||
Probability of completing a Business Combination |
% | |||
Term (in years) |
||||
Volatility |
||||
Risk-free rate |
% | |||
Fair value of warrants |
$ |
As of March 4, 2021 |
As 2021 |
|||||||
Stock price |
$ | $ | ||||||
Strike price |
$ | $ | ||||||
Probability of completing a Business Combination |
% | * | ||||||
Dividend yield |
% | % | ||||||
Term (in years) |
||||||||
Volatility |
% | % | ||||||
Risk-free rate |
% | % | ||||||
Fair value of warrants |
$ | $ |
* |
The probability of completing a Business Combination is considered within the volatility implied by the traded price of the Public Warrants which is used to value the Private Placement Warrants. |
Private Placement |
Public |
Warrant Liabilities |
||||||||||
Fair value as of September 30, 2020 |
$ | — | $ | — | $ | — | ||||||
Initial measurement as of March 4, 2021 |
||||||||||||
Additional warrants issued in over-allotment |
||||||||||||
Change in valuation inputs or other assumptions |
( |
) |
( |
) |
( |
) | ||||||
|
|
|
|
|
|
|||||||
Fair value as of September 30, 2021 |
$ |
$ |
$ |
|||||||||
|
|
|
|
|
|
* | Filed herewith. |
** | Furnished. |
Haymaker Acquisition Corp. III | ||||||
Date: November 29, 2021 | By: | /s/ Steven J. Heyer | ||||
Name: Steven J. Heyer | ||||||
Title: Chief Executive Officer |
Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Steven J. Heyer, certify that:
1. I have reviewed this quarterly report on Form 10-Q/A of Haymaker Acquisition Corp. III;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and
b) (Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);
c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: November 29, 2021 | ||||||
By: | /s/ Steven J. Heyer | |||||
Steven J. Heyer | ||||||
Chief Executive Officer | ||||||
(Principal Executive Officer) |
Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Christopher Bradley, certify that:
1. I have reviewed this quarterly report on Form 10-Q/A of Haymaker Acquisition Corp. III;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and
b) (Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);
c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: November 29, 2021 | ||||||
By: | /s/ Christopher Bradley | |||||
Christopher Bradley | ||||||
Chief Financial Officer | ||||||
(Principal Financial Officer) |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Haymaker Acquisition Corp. III (the Company) on Form 10-Q/A for the quarterly period ended September 30, 2021, as filed with the Securities and Exchange Commission (the Report), I, Steven J. Heyer, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.
Date: November 29, 2021 | ||||||
By: | /s/ Steven J. Heyer | |||||
Steven J. Heyer | ||||||
Chief Executive Officer | ||||||
(Principal Executive Officer) |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Haymaker Acquisition Corp. III (the Company) on Form 10-Q/A for the quarterly period ended September 30, 2021, as filed with the Securities and Exchange Commission (the Report), I, Christopher Bradley, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.
Date: November 29, 2021 | ||||||
By: | /s/ Christopher Bradley | |||||
Christopher Bradley | ||||||
Chief Financial Officer | ||||||
(Principal Financial Officer) |